XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |